
Brilivog 0.3 Tablet
Marketer
Osiante Biotech
Salt Composition
Voglibose (0.3mg)
Overview Brilivog 0.3 Tablet
Glavoglin 0.3mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (elevated blood sugar after meals). It's prescribed when dietary modifications and other antidiabetic agents prove insufficient to achieve adequate glycemic control. Glavoglin 0.3mg tablets should be administered immediately prior to meals. Dosage and frequency are determined by your physician to optimize blood glucose regulation. Discontinuation should only occur under medical supervision; abrupt cessation may result in hyperglycemia and associated risks including nephropathy and retinopathy. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include abdominal distension, stomach discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. Although Glavoglin 0.3mg tablets alone do not typically induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose (dextrose) should be used to treat hypoglycemic episodes; sucrose is ineffective in this context. Prior to commencing treatment, inform your doctor of any renal or hepatic impairment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating women should seek medical advice before initiating therapy. Comprehensive disclosure of all other medications is crucial for safe and effective treatment. Limit alcohol consumption while taking this medication to minimize the risk of hypoglycemia.
Primary Ingredients of Brilivog 0.3 Tablet
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Brilivog 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Brilivog 0.3 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. For optimal absorption, take Brilivog 0.3 Tablet on an empty stomach.
Common Side effects of Brilivog 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Brilivog 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Brilivog 0.3 Tablet on an empty stomach.
How Brilivog 0.3 Tablet works:
Brilivog 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus mitigating post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Brilivog 0.3 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Brilivog 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Brilivog 0.3 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Brilivog 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Brilivog 0.3 Tablet cautiously, potentially requiring a modified dosage. Physician consultation is recommended.
LiverCAUTION
Individuals with advanced hepatic impairment should exercise caution when using Brilivog 0.3 mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Brilivog 0.3 Tablet :
Omit any missed Brilivog 0.3 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Brilivog 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Category | Alpha-glucosidase inhibitors |
